AI-Designed TB treatment could be safer and more effective than standard care
Disease control
Not yet recruiting
This study tests whether a two-drug combination (pyrazinamide and hydroxychloroquine) chosen by artificial intelligence works better than the usual four-drug regimen for adults with new, drug-sensitive lung tuberculosis. About 200 participants will receive either the AI-optimized…
Phase: PHASE2 • Sponsor: Ministry of Health, Saudi Arabia • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC